Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants
Seth J. Zost(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Doan C. Nguyen(Emory University), Lauren E. Williamson(Vanderbilt University Medical Center), Nathaniel S. Chapman(University of North Carolina at Chapel Hill), Stacey A. Rutherford(The University of Texas Health Science Center at Tyler), Elad Binshtein, Naveenchandra Suryadevara(Vanderbilt University), Nicholas Catanzaro(University of North Carolina at Chapel Hill), Andrew Trivette, Nicole V. Johnson(The University of Texas at Austin), Suzanne M. Scheaffer(Washington University in St. Louis), Ajit R. Ramamohan(The University of Texas at Austin), Cameron D. Buchman, James R. Martinez, Silvia Ravera, Eduardo Villalobos, Luke Myers, Ralph S. Baric(University of North Carolina at Chapel Hill), Alexandra Schäfer(University of North Carolina at Chapel Hill), Jason S. McLellan, Michael S. Diamond, Laura S. Handal, F. Eun-Hyung Lee, Robert H. Carnahan(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k